-
- Bushra Ateeq
- Michigan Center for Translational Pathology, Ann Arbor, MI 48109, USA.
-
- Scott A. Tomlins
- Michigan Center for Translational Pathology, Ann Arbor, MI 48109, USA.
-
- Bharathi Laxman
- Michigan Center for Translational Pathology, Ann Arbor, MI 48109, USA.
-
- Irfan A. Asangani
- Michigan Center for Translational Pathology, Ann Arbor, MI 48109, USA.
-
- Qi Cao
- Michigan Center for Translational Pathology, Ann Arbor, MI 48109, USA.
-
- Xuhong Cao
- Michigan Center for Translational Pathology, Ann Arbor, MI 48109, USA.
-
- Yong Li
- Michigan Center for Translational Pathology, Ann Arbor, MI 48109, USA.
-
- Xiaoju Wang
- Michigan Center for Translational Pathology, Ann Arbor, MI 48109, USA.
-
- Felix Y. Feng
- Michigan Center for Translational Pathology, Ann Arbor, MI 48109, USA.
-
- Kenneth J. Pienta
- Michigan Center for Translational Pathology, Ann Arbor, MI 48109, USA.
-
- Sooryanarayana Varambally
- Michigan Center for Translational Pathology, Ann Arbor, MI 48109, USA.
-
- Arul M. Chinnaiyan
- Michigan Center for Translational Pathology, Ann Arbor, MI 48109, USA.
書誌事項
- 公開日
- 2011-03-02
- DOI
-
- 10.1126/scitranslmed.3001498
- 公開者
- American Association for the Advancement of Science (AAAS)
この論文をさがす
説明
<jats:p> SPINK1 is a therapeutic target in a subset of patients with <jats:italic> SPINK1 <jats:sup>+</jats:sup> /ETS <jats:sup>−</jats:sup> </jats:italic> prostate cancer. </jats:p>
収録刊行物
-
- Science Translational Medicine
-
Science Translational Medicine 3 (72), 72ra17-, 2011-03-02
American Association for the Advancement of Science (AAAS)
